Symposiums

The symposium addressed the efficacy and safety of compounds currently available for treatment of hepatitis C virus (HCV) and chronic kidney disease…

Inflammatory bowel disease (IBD) describes two inflammatory conditions of the gastrointestinal tract: ulcerative colitis (UC) and Crohn’s disease (CD)…

Inflammatory bowel disease (IBD) management goals have recently focussed on gastrointestinal symptom resolution and mucosal healing. IBD causes systemic…

CD is a complex disease, which requires effective treatment options to improve the quality of life for patients.

The treatment landscape of ulcerative colitis (UC) is changing, with new treatment options becoming available and insights into disease management…

Prof Per-Uno Malmström opened this symposium on non-muscle invasive bladder cancer (NMIBC) by describing the medical and economic burden caused by the…

Prof Gerd Horneff opened the symposium with a summary of the recent advances in the understanding of the role of interleukin (IL)-1β in the pathogenesis…

Lysosomal acid lipase deficiency (LAL-D), historically known as Wolman’s disease or cholesteryl ester storage disease, is a severe, underdiagnosed, and…